Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
PLoS One ; 19(10): e0308649, 2024.
Artículo en Inglés | MEDLINE | ID: mdl-39413126

RESUMEN

This study aimed to evaluate the ability of pentoxifylline when compared to lovastatin and chlorpromazine as nephroprotective substances in cases of renal ischemia and reperfusion syndrome (IRI). A total of 36 adult male animals were randomly allocated into four groups (untreated control group, pentoxifylline group, lovastatin group, and chlorpromazine group), each consisting of nine animals. All groups were submitted to experimental ischemia and reperfusion procedures. The animals were evaluated 24, 72 and 120 hours after IRI, including physical examinations, serum urea and creatinine measurements, as well as histopathological, morphometric, and stereological analyses of the renal tissue. Results indicated that 24 hours after IRI, only chlorpromazine was effective in controlling azotemia. At the 72-hour mark, both chlorpromazine and pentoxifylline exhibited efficacy. After 120 hours, all three substances demonstrated renal protective qualities. Pentoxifylline was the most effective in preserving the structural integrity of kidney tissue, followed by chlorpromazine. In conclusion, all three treatments (pentoxifylline, chlorpromazine, and lovastatin) were effective. Pentoxifylline proved to be promising in the response against acute tubular necrosis, although chlorpromazine presented earlier renoprotective effects in terms of maintaining renal function.


Asunto(s)
Clorpromazina , Riñón , Lovastatina , Pentoxifilina , Daño por Reperfusión , Animales , Clorpromazina/farmacología , Clorpromazina/uso terapéutico , Pentoxifilina/farmacología , Pentoxifilina/uso terapéutico , Daño por Reperfusión/tratamiento farmacológico , Daño por Reperfusión/prevención & control , Daño por Reperfusión/patología , Masculino , Lovastatina/farmacología , Lovastatina/uso terapéutico , Riñón/efectos de los fármacos , Riñón/patología , Ratas , Creatinina/sangre , Sustancias Protectoras/farmacología , Sustancias Protectoras/uso terapéutico , Ratas Wistar
2.
Domest Anim Endocrinol ; 89: 106871, 2024 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-39032188

RESUMEN

Trilostane is the current treatment of choice for managing pituitary-dependent hypercortisolism (PDH) in dogs. While prescribing higher initial doses may elevate the risk of iatrogenic hypocortisolism, opting for more conservative approach could result in delayed disease control, since most individuals end up requiring dosage increases. The adrenocorticotrophin stimulation test (ACTHst), a widely recognized hormonal test for assessing adrenal function, is an essential tool for monitoring the pharmacological treatment of canine hypercortisolism (CH) that can also be used for diagnostic purposes. The aim of this study was to investigate the relationship between post-ACTH cortisol (cpACTH) at PDH diagnosis and the required trilostane dose for sign control and endogenous cortisol regulation in dogs, considering a hypothesis that higher serum cpACTH concentration would necessitate a higher trilostane dosage for disease management. Data for 43 dogs with PDH had their diagnostic cpACTH recorded and correlated to the trilostane dosage necessary to control clinical signs and achieve satisfactory cortisol levels (ideally 2-7 µg/dL). The odds ratio (p=0.042) suggests that dogs with cpACTH ≥ 27 µg/dL at diagnosis are 96% more likely to need a higher trilostane dosage for achieving satisfactory control of PDH. Thus, cpACTH was found to be associated with the final trilostane dose for controlling PDH in dogs.


Asunto(s)
Hormona Adrenocorticotrópica , Dihidrotestosterona , Enfermedades de los Perros , Hidrocortisona , Animales , Perros , Enfermedades de los Perros/tratamiento farmacológico , Hidrocortisona/sangre , Dihidrotestosterona/análogos & derivados , Hormona Adrenocorticotrópica/sangre , Masculino , Femenino , Síndrome de Cushing/veterinaria , Síndrome de Cushing/tratamiento farmacológico , Síndrome de Cushing/sangre , Relación Dosis-Respuesta a Droga , Hipersecreción de la Hormona Adrenocorticotrópica Pituitaria (HACT)/veterinaria , Hipersecreción de la Hormona Adrenocorticotrópica Pituitaria (HACT)/tratamiento farmacológico
3.
Ann Endocrinol (Paris) ; 82(2): 107-111, 2021 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-33727117

RESUMEN

Acromegaly is an endocrine disease that leads to elevated production and secretion of growth hormone (GH). It can occur in adult and aged cats and is usually associated with neoplasms, such as functional pituitary macroadenoma of somatotropic cells. In dogs it is usually related to an increase in serum progesterone that induces production of GH by the mammary glands. The main clinical signs are related to insulin resistance and the anabolic effect induced by GH: polyuria, polydipsia, polyphagia, increased tissue growth, weight gain, prognathism, and other changes. The condition can be diagnosed from clinical signals and imaging associated to measurement of serum concentrations of GH and insulin-like growth factor 1 (IGF-1, also known as somatomedin C). The main therapeutic modalities are radiotherapy, hypophysectomy, and several drugs such as somatostatin analogs, dopaminergic agonists and GH receptor antagonists. The present review aims to provide a relevant animal model of acromegaly with an update on the therapeutic approach that may help clinicians to consider the GH axis-IGF-1 system, its pathogenesis and the clinical signs induced by this hormonal disorder.


Asunto(s)
Acromegalia/veterinaria , Enfermedades de los Gatos , Enfermedades de los Perros , Acromegalia/diagnóstico , Acromegalia/terapia , Animales , Enfermedades de los Gatos/diagnóstico , Enfermedades de los Gatos/terapia , Gatos , Enfermedades de los Perros/diagnóstico , Enfermedades de los Perros/terapia , Perros , Agonistas de Dopamina/uso terapéutico , Hormona del Crecimiento/metabolismo , Hipofisectomía , Resistencia a la Insulina , Factor I del Crecimiento Similar a la Insulina/fisiología , Radioterapia , Somatostatina/análogos & derivados
4.
Rev. bras. ciênc. vet ; 23(3-4): 133-137, jul./dez. 2016. il.
Artículo en Inglés | LILACS | ID: biblio-967971

RESUMEN

This study evaluated the microbiological quality of the water of 33 poultry sheds seeking to identify the presence of biofilm-producing Escherichia coli. The swab samples of the surface of the drinkers were analyzed by the inhibition test to detect the most effective disinfectant for removing these bacterial communities. The multiple-tube and mesophilic counts techniques were used to analyze the water samples. The swabs were plated on EMB agar followed by Rugai medium to identify E. coli. The biofilm was detected by the optical density readings and the Congo red agar method. Overall, 15 strains of Escherichia coli were detected in the swabs of the drinkers, of which 8 were biofilm producers. Regarding the water quality, 15 (45.45%) of the 33 evaluated water samples had bacterial growth while only two (13.33%) produced gas. The test with disinfectants showed that chlorine and chlorhexidine were not effective to control the E. coli biofilm production. Therefore, a strict control is essential to ensure the safety of the water supplied to the animals in broiler sheds and to eliminate the biofilm-forming E. coli that have shown to be potentially resistant to the sanitizers commonly used in the cleaning processes.


Objetivou-se avaliar a qualidade microbiológica da água de 33 galpões avícolas, identificar a presença de Escherichia coli produtoras de biofilmes em amostras de suabes de superfície dos bebedouros e analisar por teste de inibição o desinfetante mais eficiente para remoção dessas comunidades bacterianas. Foi utilizada a técnica dos tubos múltiplos e contagem de mesófilas para as amostras de água. Os suabes foram semeados em Ágar EMB, e posteriormente em meio Rugai para identificação de E. coli. Para análise de produção de biofilme foi feita a leitura da Densidade Óptica e o método do Ágar Vermelho Congo. Foram identificadas 15 cepas de E. coli nos suabes de bebedouros, sendo que 8 foram produtoras de biofilme. Quanto ao padrão de qualidade da água, observou-se que das 33 amostras de água avaliadas, 15 (45,45%) tiveram crescimento bacteriano, sendo que somente duas (13,33%) produziram gás. Para o teste com desinfetantes, o cloro e o clorexidine não se mostraram eficientes no controle da produção de biofilmes de E. coli. Dessa forma, torna-se essencial o controle rigoroso nos galpões de frangos de corte para garantir a inocuidade da água fornecida aos animais e a eliminação de E. coli potencialmente formadoras de biofilmes resistentes aos sanitizantes mais comumente usados nos processos de limpeza.


Asunto(s)
Animales , Control de la Calidad del Agua , Escherichia coli
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA